Wells Fargo Raises Kyverna Therapeutics (KYTX) PT to $27 on Confidence in KYV-101 Stiff Person Syndrome Trial Readout

finance.yahoo.com/news/wells-fargo-raises-kyverna-therapeutics-135932914.html

Wells Fargo Raises Kyverna Therapeutics (KYTX) PT to $27 on Confidence in KYV-101 Stiff Person Syndrome Trial Readout
Kyverna Therapeutics Inc. (NASDAQ:KYTX) is one of the best young stocks with huge upside potential. On October 8, Wells Fargo analyst Derek Archila raised the firm’s…

This story appeared on finance.yahoo.com, 2025-10-17 13:59:32.
The Entire Business World on a Single Page. Free to Use →